Prostate Cancer Clinical Trial

July 5, 2018

Prostate Cancer Clinical Trial

Other than non-melanoma skin cancer, prostate cancer is the most common cancer in American men It is estimated that 1 in 9 men will be diagnosed with prostate cancer in his lifetime. It is the second leading cause of cancer death in American men.

Arizona Oncology’s Curtis Mack, MD is currently part of a nationwide clinical trial with NRG Oncology that is evaluating the outcomes of reducing the number of radiation treatment days to as few as five. Currently most patients receive between 28 and 44 treatments.

As a member of US Oncology Research, Arizona Oncology provides our patients access to cutting-edge and innovative clinical trials in a comfortable and convenient setting. One of the largest and most reputable community-based research networks in the world, US Oncology Research specializes in Phase I–IV oncology clinical trials and has participated in over 1,200 investigator-initiated and sponsor-initiated trials since its inception.

To learn more about this trial and to see if you qualify please contact Arizona Oncology’s Orange Grove Radiation office:  1845 W. Orange Grove, Bldg. 1 / Phone: (520) 544-2919

Categories: